These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235 [TBL] [Abstract][Full Text] [Related]
4. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822 [TBL] [Abstract][Full Text] [Related]
5. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer. Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342 [TBL] [Abstract][Full Text] [Related]
6. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726 [TBL] [Abstract][Full Text] [Related]
7. Fer kinase regulates cell migration through α-dystroglycan glycosylation. Yoneyama T; Angata K; Bao X; Courtneidge S; Chanda SK; Fukuda M Mol Biol Cell; 2012 Mar; 23(5):771-80. PubMed ID: 22238358 [TBL] [Abstract][Full Text] [Related]
8. The inside and out of dystroglycan post-translational modification. Moore CJ; Winder SJ Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978 [TBL] [Abstract][Full Text] [Related]
9. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969 [TBL] [Abstract][Full Text] [Related]
10. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy. Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP Elife; 2023 Feb; 12():. PubMed ID: 36723429 [TBL] [Abstract][Full Text] [Related]
11. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576 [TBL] [Abstract][Full Text] [Related]
12. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding. Zhang Z; Zhang P; Hu H PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062 [TBL] [Abstract][Full Text] [Related]
13. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding. Patnaik SK; Stanley P J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414 [TBL] [Abstract][Full Text] [Related]
14. Abnormal glycosylation of dystroglycan in human genetic disease. Hewitt JE Biochim Biophys Acta; 2009 Sep; 1792(9):853-61. PubMed ID: 19539754 [TBL] [Abstract][Full Text] [Related]
15. Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes. Akhavan A; Griffith OL; Soroceanu L; Leonoudakis D; Luciani-Torres MG; Daemen A; Gray JW; Muschler JL Cancer Res; 2012 May; 72(10):2578-88. PubMed ID: 22589276 [TBL] [Abstract][Full Text] [Related]
16. Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle. Brockington M; Torelli S; Sharp PS; Liu K; Cirak S; Brown SC; Wells DJ; Muntoni F PLoS One; 2010 Dec; 5(12):e14434. PubMed ID: 21203384 [TBL] [Abstract][Full Text] [Related]
17. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies. Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448 [TBL] [Abstract][Full Text] [Related]
18. A tumor suppressor function of laminin-binding alpha-dystroglycan. Bao X; Fukuda M Methods Enzymol; 2010; 479():387-96. PubMed ID: 20816178 [TBL] [Abstract][Full Text] [Related]
19. Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis. Zhang HZ; Xia XY; Zhu F; Shen H; Song K; Shang ZJ J Oral Maxillofac Surg; 2014 Jun; 72(6):1106-18. PubMed ID: 24629698 [TBL] [Abstract][Full Text] [Related]
20. Endocytic trafficking of laminin is controlled by dystroglycan and is disrupted in cancers. Leonoudakis D; Huang G; Akhavan A; Fata JE; Singh M; Gray JW; Muschler JL J Cell Sci; 2014 Nov; 127(Pt 22):4894-903. PubMed ID: 25217627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]